Market squeeze on medical research

Artificial oocyte activation improves ICSI outcomes following unexplained fertilization abnormalities.

Reproductive biomedicine online·2024

Five-Year Follow-Up of a Slowly Resorbable Biosynthetic P4HB Mesh (Phasix) in VHWG Grade 3 Incisional Hernia Repair.

Annals of surgery open : perspectives of surgical history, education, and clinical approaches·2023

Sequence Variant in the TRIM39-RPP21 Gene Readthrough is Shared Across a Cohort of Arabian Foals Diagnosed with Juvenile Idiopathic Epilepsy.

Journal of genetic mutation disorders·2022

Antimicrobial use in agriculture: critical review of the factors influencing behaviour.

JAC-antimicrobial resistance·2021

Understanding farmers' and veterinarians' behavior in relation to antimicrobial use and resistance in dairy cattle: A systematic review.

Journal of dairy science·2021

Chemically Modified Variants of Fenofibrate with Antiglioblastoma Potential.

Translational oncology·2019

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Multiple prodrug approach for topical application: flux across silicone membranes upon simultaneous administration of salicylate esters.

International journal of pharmaceutics·2026

Prevalence and Clinical Characteristics of Vitiligo-Associated Hearing Loss Among Patients in a Phase 2 Clinical Trial of Povorcitinib.

Dermatology and therapy·2026

The past, the present, and the future of preclinical mouse models for Alzheimer's disease and related dementias.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

A theranostic wearable laser-induced graphene-hydrogel dressing for synergistic treatment and real-time monitoring of dermatophytosis.

Bioactive materials·2026

Busulfan exposure variability and acute toxicity in pediatric patients undergoing hematopoietic stem cell gene therapy.

Frontiers in pharmacology·2026

Integrating the Metaverse Into Medical Practice: A Systematic Review of Its Potential and Applications.

International journal of telemedicine and applications·2026

Related Experiment Videos

Market squeeze on medical research

Related Concept Videos

Artificial oocyte activation improves ICSI outcomes following unexplained fertilization abnormalities.

Five-Year Follow-Up of a Slowly Resorbable Biosynthetic P4HB Mesh (Phasix) in VHWG Grade 3 Incisional Hernia Repair.

Sequence Variant in the TRIM39-RPP21 Gene Readthrough is Shared Across a Cohort of Arabian Foals Diagnosed with Juvenile Idiopathic Epilepsy.

Antimicrobial use in agriculture: critical review of the factors influencing behaviour.

Understanding farmers' and veterinarians' behavior in relation to antimicrobial use and resistance in dairy cattle: A systematic review.

Chemically Modified Variants of Fenofibrate with Antiglioblastoma Potential.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Multiple prodrug approach for topical application: flux across silicone membranes upon simultaneous administration of salicylate esters.

Prevalence and Clinical Characteristics of Vitiligo-Associated Hearing Loss Among Patients in a Phase 2 Clinical Trial of Povorcitinib.

The past, the present, and the future of preclinical mouse models for Alzheimer's disease and related dementias.

A theranostic wearable laser-induced graphene-hydrogel dressing for synergistic treatment and real-time monitoring of dermatophytosis.

Busulfan exposure variability and acute toxicity in pediatric patients undergoing hematopoietic stem cell gene therapy.

Integrating the Metaverse Into Medical Practice: A Systematic Review of Its Potential and Applications.

Related Experiment Videos

Market squeeze on medical research

Related Concept Videos

Related Articles